Healthequity Inc (HQY) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Healthequity Inc (NASDAQ:HQY) have earned an average rating of “Buy” from the fifteen research firms that are covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $95.17.
A number of equities analysts have commented on the stock. Citigroup reiterated a “buy” rating and issued a $110.00 price objective on shares of Healthequity in a report on Wednesday, September 5th. Cantor Fitzgerald boosted their price objective on shares of Healthequity from $68.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, September 5th. Zacks Investment Research upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, August 7th. Raymond James boosted their price objective on shares of Healthequity from $85.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, September 10th. Finally, KeyCorp boosted their price objective on shares of Healthequity from $90.00 to $105.00 and gave the stock an “overweight” rating in a report on Tuesday, September 4th.
Shares of Healthequity stock opened at $85.30 on Monday. Healthequity has a twelve month low of $42.92 and a twelve month high of $101.58. The firm has a market cap of $5.29 billion, a P/E ratio of 110.78, a price-to-earnings-growth ratio of 2.96 and a beta of 1.39.
In other news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction dated Thursday, September 20th. The shares were sold at an average price of $92.93, for a total value of $371,720.00. Following the sale, the vice president now owns 96,100 shares in the company, valued at approximately $8,930,573. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 4.00% of the company’s stock.
Institutional investors have recently modified their holdings of the company. Advisors Asset Management Inc. raised its stake in shares of Healthequity by 5,212.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 72,086 shares of the company’s stock valued at $160,000 after purchasing an additional 70,729 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Healthequity in the 3rd quarter valued at about $172,000. Rockefeller Capital Management L.P. acquired a new stake in shares of Healthequity in the 2nd quarter valued at about $179,000. Cerebellum GP LLC acquired a new stake in shares of Healthequity in the 3rd quarter valued at about $185,000. Finally, S&CO Inc. acquired a new stake in shares of Healthequity in the 2nd quarter valued at about $204,000. Institutional investors and hedge funds own 96.35% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading: NASDAQ Stock Market Explained
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.